ROIV logo

Roivant Sciences (ROIV) EBIT

annual EBIT:

-$1.11B-$288.75M(-35.00%)
March 1, 2025

Summary

  • As of today (July 3, 2025), ROIV annual earnings before interest & taxes is -$1.11 billion, with the most recent change of -$288.75 million (-35.00%) on March 1, 2025.
  • During the last 3 years, ROIV annual EBIT has fallen by -$196.97 million (-21.49%).
  • ROIV annual EBIT is now -37.66% below its all-time high of -$809.01 million, reached on March 31, 2023.

Performance

ROIV EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherROIVincome statement metrics

quarterly EBIT:

-$284.96M-$10.58M(-3.86%)
March 1, 2025

Summary

  • As of today (July 3, 2025), ROIV quarterly earnings before interest & taxes is -$284.96 million, with the most recent change of -$10.58 million (-3.86%) on March 1, 2025.
  • Over the past year, ROIV quarterly EBIT has dropped by -$78.13 million (-37.77%).
  • ROIV quarterly EBIT is now -231.19% below its all-time high of $217.21 million, reached on March 31, 2023.

Performance

ROIV quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherROIVincome statement metrics

TTM EBIT:

-$817.51M-$78.13M(-10.57%)
March 1, 2025

Summary

  • As of today (July 3, 2025), ROIV TTM earnings before interest & taxes is -$817.51 million, with the most recent change of -$78.13 million (-10.57%) on March 1, 2025.
  • Over the past year, ROIV TTM EBIT has increased by +$127.40 million (+13.48%).
  • ROIV TTM EBIT is now -614.28% below its all-time high of -$114.45 million, reached on June 1, 2020.

Performance

ROIV TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherROIVincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ROIV EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.0%-37.8%+13.5%
3 y3 years-21.5%+1.7%+10.8%
5 y5 years-24.3%-149.0%-614.3%

ROIV EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.7%at low-231.2%+23.7%-57.0%+37.9%
5 y5-year-37.7%at low-231.2%+23.7%-614.3%+37.9%
alltimeall time-37.7%at low-231.2%+23.7%-614.3%+37.9%

ROIV EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-$1.11B(+35.0%)
-$284.96M(+3.9%)
-$817.51M(+10.6%)
Dec 2024
-
-$274.38M(-19.7%)
-$739.38M(+7.8%)
Sep 2024
-
-$341.71M(-509.0%)
-$685.96M(+26.1%)
Jun 2024
-
$83.54M(-140.4%)
-$544.19M(-42.4%)
Mar 2024
-$824.93M(+2.0%)
-$206.83M(-6.4%)
-$944.91M(+81.4%)
Dec 2023
-
-$220.96M(+10.5%)
-$520.87M(-22.7%)
Sep 2023
-
-$199.94M(-37.0%)
-$673.54M(-13.5%)
Jun 2023
-
-$317.18M(-246.0%)
-$779.02M(-3.7%)
Mar 2023
-$809.01M
$217.21M(-158.1%)
-$809.01M(-38.5%)
Dec 2022
-
-$373.63M(+22.3%)
-$1.32B(+5.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$305.42M(-12.0%)
-$1.25B(+7.0%)
Jun 2022
-
-$347.17M(+19.7%)
-$1.17B(+27.1%)
Mar 2022
-$916.71M(+2.3%)
-$290.00M(-4.8%)
-$916.71M(-7.6%)
Dec 2021
-
-$304.55M(+36.1%)
-$992.38M(+4.8%)
Sep 2021
-
-$223.69M(+127.2%)
-$946.90M(+7.6%)
Jun 2021
-
-$98.47M(-73.1%)
-$879.76M(-1.8%)
Mar 2021
-$895.74M
-$365.67M(+41.1%)
-$895.74M(+69.0%)
Dec 2020
-
-$259.07M(+65.5%)
-$530.06M(+95.6%)
Sep 2020
-
-$156.54M(+36.8%)
-$270.99M(+136.8%)
Jun 2020
-
-$114.45M
-$114.45M

FAQ

  • What is Roivant Sciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Roivant Sciences?
  • What is Roivant Sciences annual EBIT year-on-year change?
  • What is Roivant Sciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Roivant Sciences?
  • What is Roivant Sciences quarterly EBIT year-on-year change?
  • What is Roivant Sciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Roivant Sciences?
  • What is Roivant Sciences TTM EBIT year-on-year change?

What is Roivant Sciences annual earnings before interest & taxes?

The current annual EBIT of ROIV is -$1.11B

What is the all time high annual EBIT for Roivant Sciences?

Roivant Sciences all-time high annual earnings before interest & taxes is -$809.01M

What is Roivant Sciences annual EBIT year-on-year change?

Over the past year, ROIV annual earnings before interest & taxes has changed by -$288.75M (-35.00%)

What is Roivant Sciences quarterly earnings before interest & taxes?

The current quarterly EBIT of ROIV is -$284.96M

What is the all time high quarterly EBIT for Roivant Sciences?

Roivant Sciences all-time high quarterly earnings before interest & taxes is $217.21M

What is Roivant Sciences quarterly EBIT year-on-year change?

Over the past year, ROIV quarterly earnings before interest & taxes has changed by -$78.13M (-37.77%)

What is Roivant Sciences TTM earnings before interest & taxes?

The current TTM EBIT of ROIV is -$817.51M

What is the all time high TTM EBIT for Roivant Sciences?

Roivant Sciences all-time high TTM earnings before interest & taxes is -$114.45M

What is Roivant Sciences TTM EBIT year-on-year change?

Over the past year, ROIV TTM earnings before interest & taxes has changed by +$127.40M (+13.48%)
On this page